Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E8VD
|
||||
| Former ID |
DNC014343
|
||||
| Drug Name |
Erythribyssin L
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530829] | ||
| Formula |
C25H28O5
|
||||
| Canonical SMILES |
CC(=CCC1=C(C=CC2=C1OC3C2COC4=C3C=C5CC(C(OC5=C4)(C)C)O)O<br />)C
|
||||
| InChI |
1S/C25H28O5/c1-13(2)5-6-16-19(26)8-7-15-18-12-28-21-11-20-14(10-22(27)25(3,4)30-20)9-17(21)24(18)29-23(15)16/h5,7-9,11,18,22,24,26-27H,6,10,12H2,1-4H3/t18-,22?,24-/m0/s1
|
||||
| InChIKey |
HAOOQCMPFMLAJM-HRKCMRQESA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530829] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||